Mammary epithelial cells in primary cell culture require both growth factors and specific extracellular matrix (ECM)-attachment for survival. Here we demonstrate for the first time that inhibition of the ECM-induced Erk 1/Erk 2 (p42/44 MAPK) pathway, by PD 98059, leads to apoptosis in these cells. Associated with this cell death is a possible compensatory signalling through the p38 MAP kinase pathway the inhibition of which, by SB 203580, leads to a more rapid onset of apoptosis. This provides evidence for a hitherto undescribed Erk 1/Erk 2 to p38 MAP kinase pathwaỳ cross-talk' that is essential for the survival of these cells. The cell death associated with inhibition of these two MAP kinase pathways however, occurred in the presence of insulin that activates the classical PI-3 kinase-dependent Akt/PKB survival signals and Akt phosphorylation. Cell death induced by inhibition of the MAP kinase pathways did not affect Akt phosphorylation and may, thus, be independent of PI-3 kinase signalling. Cell Death and Differentiation (2000) 7, 302 ± 313.
Introduction
Pregnancy is associated with an extensive expansion of mammary epithelial cell numbers as the milk secreting alveoli are generated. In mid-to-late pregnancy these alveolar epithelial cells differentiate in response to lactogenic hormones, particularly prolactin. It is hypothesised that the alveolar epithelial cells, once differentiated, are programmed to die and require survival factors for their functional maintenance throughout the remainder of pregnancy and during lactation, until they die by apoptosis in the postweaning involution period.
1,2 A range of studies have characterised insulin/IGF-1, 3 ± 7 hydrocortisone or progesterone, 8, 9 Stat 5a 10, 11 and the association of the mammary epithelial cells with a laminin-rich extracellular matrix (ECM) 12 ± 16 either alone or in combination, as potential survival signals for differentiated alveolar mammary epithelial cells, in vivo, and in tissue culture.
The transition of the alveolar mammary epithelial cell from the proliferating to the differentiated state, to apoptosis, seen in vivo, can be reiterated in vitro, in primary cultures of mid-pregnant mammary epithelial cells: 13,17 ± 20 The cells will proliferate in the presence of serum and growth factors (EGF); survival in the absence of growth factors can be achieved by maintaining the cells in the presence of insulin (in high concentrations) and in association with an extracellular matrix, rich in laminin (e.g. 14, 16 ); and differentiation responses (expression of milk protein genes) are observed under these latter culturing conditions in response to prolactin stimulation. 13, 20, 21 Apoptosis ensues if either of the survival factors (insulin or ECM) is omitted from the culture. The laminin-rich ECM is proposed to act through a6b1-integrin receptors to effect cell survival, at least in part, by stabilising PI-3 kinase-dependent survival responses to insulin (or IGF-1). 12, 14, 16 Insulin, in higher doses, and IGF-1 at physiological concentrations protects mammary epithelial cells from apoptosis by a PI-3 kinase-dependent mechanism, which is associated with the maintained phosphorylation of Akt. 16 It is quite possible that this latter signalling pathway causes phosphorylation of the Bcl-2 family protein Bad, and thus, causes Bad neutralisation and, hence, the anti-apoptotic influence. 22 ± 28 While these central functional requirements for cell survival responses of ECM-integrin receptor interactions are firmly established for the mammary epithelial cell, a full picture of the intracellular signalling responses to these stimuli are not.
Faraldo et al 29 disrupted b1-integrin signalling in mouse mammary gland by expression of a chimeric integrin, which uncoupled b1-integrin adhesion from intracellular signalling. This was associated with significant developmental restriction and increased apoptosis during pregnancy, reduced milk protein gene expression and apparent defects in cell polarisation during lactation, reflecting the importance of ECM-integrin signalling in the functioning gland. ECMintegrin receptor interactions in mammary epithelial cells most likely trigger formation of focal adhesion complexes with recruitment of actin-cytoskeletal anchoring components and a range of intracellular signalling molecules (reviewed in 30, 31 ). The regulatory/signalling components recruited, will for instance, include Rho which would play a key role in regulating the assembly of the adhesion complexes and associated stress fibres; Ras, Src and associated proteins, possibly MAP kinases and PI-3 kinase but with an anchoring contribution from recruited, activated focal adhesion kinase (FAK). For instance, Miyamoto et al 32 have elegantly demonstrated how integrin clustering in single fibroblasts by multivalent ligands leads to thè hierarchical' recruitment of a wide range of structural, signalling and regulatory components to focal adhesions, including Src, FAK and MAP kinase components. Integrins also recruit a range of growth factor receptors e.g. epidermal growth factor (EGF), platelet derived growth factor and basic fibroblast growth factor receptors to focal adhesions. This recruitment increases phosphorylation and activation of the growth factor receptors (GFR) implying integrin-GFR`cross-talk'. Recent reports suggest potential functional`cross-talk' in mammary epithelial cells between integrins and: the prolactin receptor signalling system; 33 the insulin receptor PI-3 kinase signalling system; 16 and, the EGF receptor signalling system. 34 While FAK phosphorylation most likely follows laminin-integrin receptor interaction in mammary epithelial cells, 35 the recruitment of other signalling components, for instance, MAP kinases and their subsequent contribution to cell signalling cell survival and differentiation responses remains undescribed.
We now report that inhibition of the MAP kinase, Erk 1/ Erk 2, signalling pathway impairs mammary epithelial cell survival in the presence of cell-ECM association and insulin. Inhibition of both the Erk 1/Erk 2 and p38 MAP kinase pathways led to a more rapid apoptotic response in the ECM-overlaid cells. We show that ECM overlay leads to a rapid short-term phosphorylation (and subsequent pulsatile phosphorylation) of Erk 1/Erk 2 but when the Erk 1/Erk 2 pathway is inhibited a slower, perhaps compensatory, activation of the p38 MAP kinase pathway in response to ECM overlay is detected. Omission of insulin from the culture medium, or selective inhibition of the PI-3 kinase signalling pathway, precipitates apoptosis of the ECMoverlaid cells and causes a loss of phosphorylation of Akt/ PKB, a known cell survival pathway that links extracellular signals to the cell death machinery. 23, 24 In contrast, apoptosis triggered by selective inhibition of the Erk 1/Erk 2 and p38 MAP kinase pathways does not affect Akt/PKB phosphorylation. This suggests the existence of an ECMdetermined MAP kinase-dependent mammary epithelial cell survival pathway that may not signal through the PI-3 kinase-Akt-associated intracellular signalling pathway.
Results
Mammary epithelial cells from mid-pregnant mice maintained in primary culture can reiterate the phases of proliferation, differentiation, survival and apoptosis characteristic of lobuloalveolar epithelial cells, in vivo.
Using nucleosomal laddering analysis to detect apoptosis, we have shown ( Figure 1A ) that such primary cultures maintained on plastic in differentiation medium (containing hydrocortisone, insulin and prolactin (see Materials and Methods)) (lane 4) display abundant nucleosomal laddering but when, in addition, are overlaid with a laminin-rich ECM (Matrigel/EHS matrix) (lane 3) are protected from cell death. When proliferating in the presence of serum, EGF and lactogenic hormones there was also no evidence of nuclear fragmentation ( Figure 1A, lane 2) . As with cells cultured in the presence of EHS ECM which showed no detectable DNA laddering ( Figure 1B, lane 2) , cells cultured in the absence of ECM but in the presence of soluble laminin also showed no significant cell death (lane 4). In contrast, cells cultured on a collagen matrix showed extensive apoptosis ( Figure 1B , lane 5) comparable to that detected in cells cultured in the absence of ECM-association (lane 3). This confirms, as suggested by the work of others, 12, 16, 36 that laminin is the component of the EHS matrix that is sufficient to determine mammary epithelial cell survival. When we assessed apoptosis by FACS cell cycle analysis using the appearance of a sub-G1/G0 peak as a cell death marker 37 ( Figure 1C ) we could again see a suppression of the apoptotic response in cells cultured in the presence of ECM overlay when compared to cells cultured in the absence of this laminin-rich matrix (compare right hand-to left handpanel). Quantitative evaluation of seven independent experiments showed that ECM overlay reduced sub-G1/G0 fluorescence by 78% (mean value). That is, ECM overlay reduced the number of sub-G1/G0 cells from 40.3% (+5.1% S.E.M.) to 9.0% (+2.1% S.E.M.) ( Figure 1C, bottom panel) . Furthermore, Figure 1D shows analysis of apoptotic death in these cells adjudged by nuclear morphology after DAPI staining (see Materials and Methods). Culturing of the cells in the presence of ECM and the lactogenic hormones, hydrocortisone, insulin and prolactin for 48 h shows only trace amounts of apoptosis (lane 1). However, omission of an ECM overlay induces a significant amount of death (P50.001) (lane 2). As will be discussed below, when the cells are cultured with both hormones and ECM overlay but in the presence of the MAP kinase inhibitors, PD 98059+SB 203580 (lane 3), or the PI 3 kinase inhibitor, LY 294002 (lane 4), we again see significant levels of apoptosis (P50.001). Thus, we show by three different techniques that in the presence of insulin a lamininrich ECM is a sufficient survival factor for cultured primary mammary epithelial cells. Also, in the presence of ECMoverlay, and on prolactin stimulation, these cells show potential for differentiation 13 (and results not shown). The analysis of the nucleosomal DNA laddering presented in Figures 1, 2 and 5 was carried out on small molecular weight DNA cellular isolates, Hirt supernatants. 38 This technique usually results in only low or negligible amounts of`carried over' high molecular weight DNA to the supernatant extract in the absence of apoptosis (e.g. Figure  1A , lane 3 and Figure 2A lanes 4 and 6) although there can be considerable variation (e.g. Figure 1B , lanes 2 and 4 and Figure 5A , upper panel, lane 2). We emphasise that the absence of a high molecular weight DNA band does not reflect a DNA sample loading error; analysis of five times the sample amount shown in Figure 1A , lane 3 still showed no evidence of nucleosomal DNA laddering (data not shown). We propose that this technique can be used to generate valid DNA laddering profiles as three different, quantitative analyses, FACS analysis ( Figure 1C ), nuclear morphology assays ( Figure 1D ) and death effector activity measurements ( Figure 2C ), all generated consistent data.
A wide range of studies (e.g. 32, 39 ) would suggest that occupation of integrin receptors by ECM ligands, with subsequent formation of focal adhesions, triggers activation of intracellular signalling cascades which modulate cellular behaviour and that MAP kinase dependent cascades are often among those activated. We investigated the dependence of ECM-determined mammary epithelial cell survival on MAP kinases using the MAPK kinase (MEK1) specific inhibitor, PD 98059, which blocks activation of the Erk 1/Erk 2 (p42/p44 MAPK) pathway. . This suggests a co-operative action between these two MAP kinase pathways in modulating ECMdetermined mammary epithelial cell survival.
We measured the commitment of the cells to apoptosis at an early time point (3 h) after ECM-overlay and MAP kinase inhibitor treatment by analysing cytochrome c loss to the cytosolic compartment 42 ± 46 and caspase 3 activation. 42 ± 49 The expected hierarchical chronology 46 would predict the cytochrome c loss and caspase 3 activation at times earlier than we had observed apoptosis (Figures 1  and 2 ). In the absence of ECM-overlay and 3 h after ECMoverlay, in the presence of PD 98059 and SB 203580, significant levels of cytosolic cytochrome c were detectable ( Figure 2B , lanes 2 and 5). In the presence of PD 98509 alone, less release was detectable (compare lanes 4 and 5). This difference is maintained at 16 h after overlay (result not shown). With ECM-overlay and no inhibitors little or no release was detectable (lane 1). Cytosolic cytochrome c is also detectable in ECM-overlaid cells cultured in the absence of insulin or in the presence of insulin and the specific PI-3 kinase inhibitor LY 294002 (lane 2 and result not shown). Caspase 3 activity was determined fluorimetrically 3 h after overlay of the mammary epithelial cells. From Figure 2C it can be seen that cells cultured in the absence of ECM-overlay show a 3.1-fold higher level of caspase 3 activity than cells cultured with ECM overlay (compare lanes 2 and 1). Cells cultured with an ECM overlay but in the presence of PD 98059 did not show a significant increase in caspase 3 activity, over basal, at this time (lane 3 and see Discussion); however, cells cultured with the ECM-overlay but in the presence PD 98059 and SB 203580 did show a significant induction (twofold) in caspase 3 activity (lane 4). Finally, cells cultured with an ECM-overlay but in the absence of insulin (lane 5) also showed a significant induction (2.9-fold) in caspase 3 activity at the 3 h time point. The apparent lesser release of cytochrome c at 3 h in the presence of PD 98059 (compared to PD 98059 + SB 203580 treatment) ( Figure  2B ) and the lower degree of activation of caspase 3 by PD 98059 treatment (again compared to the use of both MAP kinase inhibitors) ( Figure 2C ) suggests a slowness in the commitment to apoptosis when the Erk 1/Erk 2 pathway inhibitor is used and corroborates the observance of apoptosis (Figure 2A ) only after 24 h with inhibition of the Erk pathway only. Use of both inhibitors led to a higher level of cytochrome c release ( Figure 2B ), significant increase in caspase 3 activity ( Figure 2C ) and the presence of clear nucleosomal laddering even at 3 h (Figure 2A) .
Overlay of the mammary epithelial cells with ECM rapidly and transiently activated the Erk 1/Erk 2 MAP kinase pathway as monitored by Western analysis of Erk 1/Erk 2 phosphorylation using a bis-phospho (Thr 202/Tyr 204)- 
No such rapid transient induction of p38 MAP kinase phosphorylation was seen in response to ECM-overlay (results not shown). Nor was an induction of p38 MAP kinase phosphorylation, as analyzed by Western blot using a phospho-p38 MAPK specific antibody, detectable after ECM overlay in the longer term, over 24 h ( Figure 4A Figure 2A , lower panel). In addition, surviving, insulin-treated ECM-overlaid cells showed maintained levels of Akt phosphorylation over a period of 48 h after overlay ( Figure 5C , upper panels). In contrast, removal of insulin at the time of overlay led to a rapid reduction in phosphorylated Akt levels ( Figure 5C , second panels). Exposure of the insulin treated ECM-overlaid cells to LY 294002 also led to a loss of phosphorylated Akt levels in a similar time frame ( Figure 5C , third panels). However, as seen with acute insulin induction of Akt phosphorylation, treatment of the cells with PD 98059 + SB 203580 did not affect insulin-associated long-term maintenance of Akt phosphorylation ( Figure 5C , bottom panels) although inducing significant levels of cell death (see Figure 2A , bottom panel). Similarly, the Erk 1/Erk 2-pathway inhibitor, PD 98059, alone, had no effect on the insulin-maintained phospho-Akt levels (results not shown).
Lastly, we observed that inhibition of the PI-3 kinase dependent pathway (with LY 294002) was significantly more efficient (P50.05) than inhibition of the MAP kinase pathways (with PD 98059 + SB 203580) in causing apoptosis of the ECM-overlaid cells cultured in the presence of insulin ( Figure 1D, compare lanes 3 and 4) . It is noteworthy also that the presence of insulin seemed to partially protect the non-ECM-overlaid cells from apoptosis (compare lanes 2 and 4). Thus, the insulin/PI-3 kinase pathway may be the more potent survival pathway; however, inhibition of the ECM/MAP kinase pathway precipitated high levels of apoptosis (lane 3).
The data suggest that ECM overlay determines cell survival through a MAP kinase dependent mechanism that is seemingly independent of the insulin-triggered PI-3 kinase/Akt-dependent intracellular signalling pathway. It also provides evidence for a hitherto undescribed Erk 1/ Erk 2-p38 MAP kinase pathway`cross-talk' that may modulate the Erk 1/Erk 2-regulated ECM-driven survival stimulus.
Discussion
Mid-pregnant mouse mammary epithelial cells in primary culture and a number of extracellular matrix dependent Figure 1 ). The recent study of Farrelly et al 16 and other earlier studies 15, 51 show also that the survival influence of the EHS-ECM can be substituted with soluble laminin and that its influence can be negated with blocking antibodies for a6 or b1 integrins.
Treatment of the ECM-overlaid cells with the Erk 1/Erk 2 pathway inhibitor, PD 98059, in the presence of insulin, caused significant cell death after 24 ± 48 h (Figure 2A ) suggesting a dependence of mammary epithelial cell survival on an Erk 1/Erk 2-modulated pathway. ECM overlay acutely stimulated Erk 1/Erk 2 phosphorylation demonstrating a potential functional dependence of ECMinduced intracellular signalling on the Erk 1/Erk 2 pathway ( Figure 3A) and Erk 1/Erk 2 pathway signalling may be maintained by ECM, in the longer term, by pulsatile activation reflected by pulsed Erk 1/Erk 2 phosphorylation ( Figure 3B ). The cells exist in a dynamic state, whereby they must constantly be capable of perceiving cell survival signals in order to protect against apoptosis. This pulsative drive through Erk 1/Erk 2 phosphorylation may act as a potential longer-term ECM driven-epithelial cell survival pathway. The pulsatile nature of activation of the Erk 1/Erk 2 pathway is possibly consistent with the hypothesis that Erk 1/Erk 2 signalling must be down regulated in order for differentiation responses to be transduced 52 (reviewed in 31 ). However, maintained intracellular read-outs from this pulsatile Erk 1/Erk 2 signalling that are required for cell survival remain to be identified. In a fibroblast cell culture model using fibronectin stimulation, Miyamoto et al 32 have elegantly demonstrated that an ECM-b1-integrin receptor engagement, on inducing formation of focal contacts, led to a recruitment of Erk 1/Erk 2 into such contacts. These contacts also contained FAK, Ras, Raf-1, MEKK and MEK1, proven upstream modulators of Erk 1/Erk 2 phosphorylation/activation. This provides a conceptual model of how ECM-dependent survival signals would selectively activate MAP kinase pathways. FAK recruitment to focal adhesions and activation by phosphorylation on tyrosine has been functionally linked to MAP-kinase (Erk 1/Erk 2) activation in a range of model systems. 53 ± 55 Several studies have also demonstrated that ECM-integrin association with FAK initiates a survival pathway. 56, 57 In human mammary (BT474) cells Xu et al 58 demonstrated that a dominant negative form of FAK localises to focal adhesions, causes reduced FAK phosphorylation, loss of adhesion and subsequent cell death. However, FAKdependent activation of MAP-kinases in mammary epithelial cells has not been reported to date. This, in fact, is the first report of an Erk 1/Erk 2 survival pathway in mammary epithelial cells.
The Erk 1/Erk 2 pathway inhibitor, PD 98059 caused apoptotic death only after 24 h (Figure 2A) and had a weak effect on cytochrome c release and activation of caspase 3, at 3 h after ECM-overlay, while in combination with the p38 MAP kinase inhibitor, SB 203580, it caused mammary epithelial death much more rapidly and triggered cytochrome c release and caspase 3 activation more effectively (Figure 2A ). SB 203580, alone, had no effect on mammary epithelial cell survival (Figure 2A ) and ECM overlay did not trigger p38 MAP kinase phosphorylation. However, in the presence of the Erk 1/Erk 2 pathway inhibitor, p38 MAP kinase phosphorylation and activity, are slowly but transiently induced ( Figure 4A,B) . This together with the more rapid cell death associated with blocking both pathways suggests that activation of the p38 MAP kinase pathway may compensate for Erk 1/Erk 2 pathway inhibition in protecting mammary epithelial cells from apoptosis. These effects could reflect either direct or indirect functional interactions between these two MAP kinase pathways. There is evidence demonstrating opposing effects of these two signalling pathways (e.g. 59 ± 61 ) however, there are few reports of co-operative interactions between the Erk 1/Erk 2 and p38 MAP kinase pathways. 62 ± 64 Deak et al 64 have demonstrated that several growth factors stimulate both p38 MAP kinase and Erk 1/ Erk 2, and that activity of both these pathways is essential for maximal activation of the novel kinase, MSK1 (mitogen and stress activated kinase 1).
Removal of insulin from our cultures or the addition of the PI-3 kinase inhibitor, LY 294002, precipitated apoptotic cell death ( Figure 5A ) and activation of death associated processes ( Figure 2B,C) . This would reflect earlier reports by others of a role for insulin/IGF-1 in mammary epithelial cell survival 5, 65 and the existence of an insulin/IGF-1-determined PI-3 kinase-dependent survival pathway in mammary epithelial cells. 16 Activation of this pathway and the associated mammary epithelial cell survival has been linked with recruitment of PI-3 kinase to the insulin receptor-associated protein, IRS-1, and maintained phosphorylation of Akt/PKB. 16 We show ( Figure 5B ) that acute insulin stimulation of ECM-overlaid mammary epithelial cells causes PI-3 kinase-dependent Akt/PKB phosphorylation but that this is unaffected by MAP kinase pathway inhibition. In addition, cell death triggered by insulin removal or PI-3 kinase inhibition was paralleled by a rapid loss of cellular phospho-Akt while in contrast, cell death triggered by PD 98059 + SB 203580 did not affect phospho-Akt levels ( Figure 5C ). This would suggest that the MAP kinase-modulated mammary epithelial cell survival is not PI-3 kinase dependent. Although both pathways are essential for cell survival, and are seemingly independent, quantitative evaluation of the apoptotic effectiveness of inhibiting each pathway suggests a somewhat greater dependence on the PI-3 kinase Akt/PKB pathway for cell survival ( Figure 1D ).
What cellular elements do these signalling pathways target to facilitate cell survival? Members of the Bcl-2 family of pro-and anti-apoptotic proteins would seem the most likely. The pro-apoptotic protein, Bad, is maintained in an inactive form by both Akt-and PKA-catalysed phosphorylation. 23, 24, 66 There also exists evidence indicating a role for MAPK kinase (MEK1) pathway signalling in Bad phosphorylation. 67 These authors showed that GM-CSF can induce PI-3 kinase/Akt-independent phosphorylation of Bad, that inhibition of a MEK1 signalling pathway, by PD 98059, abrogated this phosphorylation and most recently that MEK-dependent phosphorylation of Bad is required for its release from its possible pro-apoptotic association with Bcl-xL . 68 These, or other modulations of Bcl-2 superfamily member activity, might provide the integrating target for the mammary epithelial cell survival pathways. This will be the focus of our future studies. Thus, inhibition of ECM-driven Erk 1/Erk 2 MAP kinase signalling slowly impairs ECMdetermined mammary epithelial cell survival. A novel compensatory triggering of the p38 MAP kinase may contribute to the slow death response to Erk 1/Erk 2 pathway inhibition alone and whilst this response is likely to be PI-3 kinase independent, its exact nature remains to be elucidated.
Materials and Methods
Primary mammary epithelial cell culture
Mouse mammary epithelial cells were prepared from mid-pregnant CD-1 mice, essentially as previously described. 13,17 ± 20 Cells were seeded on tissue culture plastic at a density of 2.4610 6 cells/ml and grown for 48 h in a proliferation medium of Hams F12 (Gibco) containing 10% heat inactivated foetal bovine serum (Gibco), epidermal growth factor (EGF), 5 ng/ml (Promega), insulin, 5 mg/ml (Sigma), hydrocortisone, 1 mg/ml (Sigma), fetuin, 1 mg/ml (Sigma) and gentamicin, 50 mg/ml (Sigma) and cultured at 378C in a humidified atmosphere of 5% CO 2 . The cells were washed and then cultured for a further 48 h in F12 medium (with gentamicin) in the presence of 10% serum, EGF, insulin and hydrocortisone. The cultures were washed extensively (with PBS) and`starved' for 6 h in F12 medium in the absence of EGF and serum, in the presence of hydrocortisone and in the presence or absence of insulin. The cultures were subsequently washed extensively and the medium changed to differentiation medium (F12, gentamicin, in the presence of hydrocortisone and in the presence or absence of insulin and prolactin, 3 mg/ml (Sigma)). The cells were then cultured in the absence or presence of an overlaid laminin-rich ECM matrix (Matrigel 1 , Becton Dickinson, 280 mg/ml, 2%) which had been diluted in the above medium 20 with or without the specific intracellular signalling pathway inhibitors, PD 98059, 10 mM, SB 203580, 1 mM or LY 294002, 10 mM, as required. After the desired time period the cells were harvested by scraping and were pelleted by centrifugation. The cell pellets were snap frozen in liquid N 2 and stored at 7808C prior to protein extract preparation.
Flow cytometric analysis (FACS analysis)
Cell nuclei were prepared for FACS analysis as described by Gurley et al. 69 Following isolation of the cell nuclei, the unfixed nuclei were either stored at 48C or used immediately for DNA analysis; 50 ml of propidium iodide solution (400 mg/ml) was added directly to the nuclear suspension without centrifugation and the nuclei stained for 30 min at room temperature in the dark. The stained nuclei were then filtered through a needle (0.50616 mm). DNA content (10 000 events) was analyzed using a FACStar Plus flow cytometer (Becton Dickinson) with laser excitation at 488 nm using a 639 nm band pass filter to collect the red propidium iodide fluorescence. The DNA content profile of the cell nuclei was analyzed using LYSIS 11 software.
Isolation of low molecular weight DNA and analysis of nucleosomal DNA laddering Low molecular weight DNA was isolated from cultured primary mammary epithelial cells using a protocol modified from that originally described by Hirt: 38 9-cm plates of cells were grown to confluency (*5610 7 cells) for each experiment. The medium was aspirated from the plates and the cells were lysed by scraping and subsequent resuspension in 10 mM Tris-HCl (pH 7.9), 5 mM EDTA (pH 8.0) and 0.5% SDS. The suspension was then adjusted to a final concentration of 1 M NaCl by the addition of volume of 5 M NaCl and incubated on ice at 48C overnight. The solution was cleared by centrifugation at 14 0006g for 30 min at 48C, 400 ml was removed and the DNA precipitated at 7208C overnight by the addition of 1/10 volume of 3 M sodium acetate and 2.5 volumes of 100% ethanol. The precipitated low molecular weight DNA was recovered by centrifugation at 14 0006g for 20 min at 48C and the pellet dried, resuspended and incubated in 10 mM Tris-HCl, pH 8.0, 1.0 mM EDTA, pH 8.0 (TE) containing 100 mg/ml RNaseA at 378C for 2 h. The resultant dissolved low molecular weight DNA was subjected to electrophoresis at 4 V/cm in a 2% agarose gel stained with ethidium bromide and the DNA subsequently visualised by UV transillumination.
Nuclear morphology assay
Primary mammary epithelial cells were grown as described above in the presence or absence of the desired inhibitors on LabTek 1 2-well Chamber Slides. After 48 h the medium was aspirated and the cells fixed in 4% paraformaldehyde in PBS for 20 min at room temperature. They were then permeabilised in 0.1% Triton X-100 in 16TBST and washed twice in 16TBST. The cells were then incubated with 5 mM 4,6-diamidino-2-phenylindole (DAPI) (Sigma Research Reagents) in PBS for 3 min and washed by immersion in 50 ml of PBS. They were then mounted in 20 ml Citifluor (Agar Scientific) before analysis on either an Olympus BX50, or a Leica Leitz DMRB, fluorescent microscope. Apoptotic cells were scored based on nuclear morphology. 16 Each treatment was analyzed three times by counting four fields (cumulatively41300 cells per four fields). Statistical analysis was carried out using the Students' t-test.
Preparation of total cellular extracts and subcellular fractions
Primary mammary epithelial cells were lysed with high salt lysis buffer (10 mM HEPES, pH 7.9, 1 mM EDTA, 0.5 mM DTT, 400 mM KCl, 1 mM Na 3 VO 4 , 1 mM b-glycerophosphate, 5 mM benzamidine, 0.2% NP-40, 10% glycerol and 1 mg/ml each of aprotinin, leupeptin and pepstatin A) by resuspension and incubated on ice for 30 min. The suspension was then cleared by centrifugation at 14 0006g for 15 min at 48C to yield supernatants comprising the total cell extract. The protocol was adapted from Eul et al 70 and Robidoux et al.
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Cytosolic extracts for cytochrome c analysis were prepared by resuspending cells in 200 ml of isotonic extraction buffer (200 mM mannitol, 70 mM sucrose, 1 mM EGTA, 10 mM HEPES, pH 7.5, 1 mM phenylmethylsulfonyl fluoride and 1 mg/ml each of leupeptin, pepstatin A and aprotinin). After incubation on ice for 1 h, cells were subjected to 30 strokes in a dounce homogeniser and subcellular particulate material removed by centrifugation at 14 0006g for 15 min at 48C to yield supernatants comprising the cytosolic extract. 72 Nuclear extracts were prepared using a protocol modified from that originally described by Osborn et al. 73 Harvested cells were resuspended in 100 ml of lysis buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, 0.2 mM PMSF, 1 mM Na 3 VO 4 , 1 mM b-glycerophosphate, 5 mM benzamidine, 0.2% NP-40, and 1 mg/ml each of aprotinin, leupeptin and pepstatin A) and incubated on ice for 15 min. The suspension was then centrifuged at 14 0006g for 10 min and the nuclear extract was obtained by resuspending the resultant pellet in 50 ± 100 ml of nuclear extraction buffer (20 mM HEPES, pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF, 1 mM Na 3 VO 4 , 1 mM b-glycerophosphate, 5 mM benzamidine, 0.2% NP-40, and 1 mg/ml each of aprotinin, leupeptin and pepstatin A) followed by incubation on ice for 30 min. The suspension was subsequently cleared by centrifugation at 14 0006g for 10 min at 48C and the supernatant retained.
Immunoblotting analysis
Cellular and subcellular extracts were resolved on SDS-polyacrylamide gels and were then electrophoretically transferred onto nitrocellulose membranes (Schleicher & Schuell). Membranes were blocked for 1 h in TBST (20 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.1% Tween) containing 5% non-fat dried milk and were incubated overnight with the appropriate primary antibody 
p38 MAP kinase assay
Total cellular extracts were prepared as described above and p38 MAP kinase was immunoprecipitated with anti-p38 antibody (5 ml/ml) overnight at 48C in immunoprecipitation buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.2 mM Na 3 VO 4 , 0.2 mM PMSF, 1% Triton X-100 and 0.5% NP-40). Immunocomplexes were captured on protein A Sepharose beads (Amersham Pharmacia Biotech) for 1 h at 48C. Beads were washed three times by centrifugation with immunoprecipitation buffer and once with p38 kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM b-glycerophosphate, 2 mM DTT, 0.1 mM Na 3 VO 4 and 10 mM MgCl 2 ). The activity of the immune complex was assayed at 308C for 30 min in 50 ml of kinase buffer containing 10 mCi [g-32 P]ATP, 30 mM ATP with 2 mg of GST-ATF-2 (New England Biolabs) as substrate. The reactions were terminated with Laemmli sample buffer 74 and proteins were resolved by SDS-polyacrylamide gel electrophoresis and visualised in a GS-250 PhosphorImager (Bio-Rad).
Caspase 3 assay
Fifty mg of total cell extract, from cells treated as required, were added to 3 ml of incubation buffer (100 mM HEPES, pH 7.5, 10% (w/v) sucrose, 0.1% (w/v) CHAPS, 10 mM DTT) containing 12 ml of caspase 3 specific substrate linked to a fluorescent moiety (Ac-DEVD-amc, 5 mM) and incubated for 30 min at 258C. Fluorescence was measured on an LS-5 Luminescence Spectrophotometer (Perkin Elmer) at 380 nm excitation and 460 nm emission peaks.
